C16 Biosciences
YC S18New York City, US · Founded 2018 · Delaware corporation · 35 employees · 9 known investors
C16 Biosciences produces high-value lipid ingredients using fermentation of naturally occurring microorganisms for manufacturers of beauty, personal care, home care, and food products. The company's biomanufacturing platform enables sustainable production with 250x greater land efficiency than traditional ingredient sources.
Also known as C16 Bio
Founders & leadership· Y Combinator alumni (S18)
C16 Biosciences was founded in 2018 by Shara Ticku, David Heller, and Harry McNamara.
Board
Investors · 9
Reported raises · per SEC filings
Form D private placements$28.9M disclosed across 3 of 4 rounds · 2018–2024
▶$5MraisedMar 2023 · 17 investors · BiotechnologyRule 506(b)
- Harold McNamaraDirector
- Shara TickuExecutive Officer, Director, Promoter
- Peter TurnerDirector
- Offering amount
- $10.2M
- Amount sold
- $5M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedMar 2020 · 45 investors · BiotechnologyRule 506(b)
- Peter TurnerDirector
- David HellerPromoter
- Shara TickuExecutive Officer, Director, Promoter
- Harold McNamaraDirector, Promoter
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$4MraisedNov 2018 · 33 investors · BiotechnologyRule 506(b)
- Harold McNamaraDirector, Promoter
- David HellerDirector, Promoter
- Andrew ShumakerDirector, Promoter
- Shara TickuExecutive Officer, Director, Promoter
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026C16 Biosciences is a New York City-based biotechnology company that produces high-value lipid ingredients through a proprietary biomanufacturing platform, marketed under the Palmless™ brand. Its stated purpose is to supply alternatives to conventional ingredient sources such as palm and palm kernel oil and petroleum derivatives, which it describes as exposed to supply and price volatility, tariffs, and consumer and regulatory pressure.
The product portfolio spans three application areas. Palmless™ Torula Oil is positioned as an emollient for beauty and personal care, described as containing antioxidant carotenoids, sterols and terpenoids, with claimed effects on skin barrier function, protection against UV rays, free radicals and environmental hazards, reduced appearance of fine lines and redness, and clinically demonstrated boosting of UVA/UVB protection in SPF formulations. In food, the company has developed a portfolio of designer fats and oils, developed with food manufacturers and demonstrated across bakery, confectionery and packaged food applications, targeting lipid functions such as mouthfeel, texture and spreadability. For home and personal care, C16 produces non-palm-kernel-oil, non-petroleum-derived fatty alcohols, fatty acids and triglycerides used in products including shampoos, soaps, toothpaste and laundry detergent.
The company describes its team as scientists, engineers, brand-builders and entrepreneurs focused on decarbonizing consumer products, and maintains a commercial advisory board that provides strategic guidance.
Business model
C16 Biosciences supplies biomanufactured ingredients to consumer goods manufacturers and brands, collaborating with partners in the beauty, personal care, home care and food sectors to incorporate its Palmless™ ingredients into their products.
Traction
The company states it has developed a portfolio of designer fats and oils with leading food manufacturers and demonstrated Palmless™ fats and oils across bakery, confectionery and packaged food applications, and that Torula Oil has been clinically shown to boost UVA and UVB protection in SPF formulations.
▸Full profile — market position, technology, go-to-market, geography
Market position
Supplier of biomanufactured lipid ingredients to consumer goods companies, competing against conventional palm-derived and petroleum-derived ingredient supply chains.
Positions its ingredients as alternatives to palm, palm kernel oil and petroleum-derived inputs, offering more predictable sourcing, reduced reliance on imported commodities, and alignment with sustainable sourcing regulations such as the EUDR and EUDDD, while claiming performance parity or improvement (for example, clinically demonstrated enhancement of SPF UVA/UVB protection).
Technology
A proprietary biomanufacturing platform used to produce high-value lipid ingredients, including Torula Oil and non-palm, non-petroleum-derived fatty alcohols, fatty acids and triglycerides. The company states the platform can be scaled locally.
Go-to-market
Direct collaboration with brands and manufacturers, with partnership inquiries solicited through the company website, supported by a press page containing press releases and media kits.
Consumer goods manufacturers and brands in beauty, personal care, home care and food, including food manufacturers formulating bakery, confectionery and packaged food products.
Geography
Headquartered in New York City; markets ingredients to consumer goods manufacturers with reference to European sustainable sourcing regulations (EUDR, EUDDD) and to reducing reliance on imported commodities.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Legal entities · 1
corporate structureIn the news
▸Research sources · 1
primary sources listed
- C16 Biosciencesc16bio.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does C16 Biosciences do?
- C16 Biosciences biomanufactures Palmless lipid ingredients for beauty, personal care, home care and food manufacturers.
- Who founded C16 Biosciences?
- C16 Biosciences was founded by Shara Ticku, David Heller, Harry McNamara in 2018.
- Who are C16 Biosciences's investors?
- C16 Biosciences's investors include Breakthrough Energy Ventures, DCVC (Data Collective), Dorm Room, E12 Venture Capital, Llc, Evolution VC Partners, Sinai Capital Partners, UpHonest Capital, Y Combinator and 1 more.
- How much funding has C16 Biosciences raised?
- C16 Biosciences has disclosed $28.9M raised across 3 of its 4 known rounds.
- Where is C16 Biosciences headquartered?
- C16 Biosciences is headquartered in New York City, US.


